The study of H.pylori third line eradication therapy using Vonopraza
Not Applicable
- Conditions
- Helicobacter pylori infection
- Registration Number
- JPRN-UMIN000024290
- Lead Sponsor
- ational Hospital Organization National Kochi Hospital gstroenterology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
Pregnancy or lactation. Past history of allergy for the drugs used in this therapy . Sever liver dysfunction, sever renal dysfunction, sever heart dysfunction. Patients who are disqualified for the sutdy by physicians.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Related study with eradication results,antimicrobial drug resisutance and H.pylori gene in H.pylori third line eradication therapy
- Secondary Outcome Measures
Name Time Method To evaluate safety of H.pylori third line eradication therapy